EMEA recommends a new warning for epoetins for their use in cancer patients

View source ↗

Summary

The EMA recommends a new warning for epoetins regarding their use in cancer patients to address safety concerns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• epoetins (erythropoiesis-stimulating agents)